In the latest talc/cancer trial, a Missouri state court jury ruled in favor of Johnson & Johnson (J&J). This follows a similar favorable ruling for the company just days ago in Philadelphia.
According to a report by Courtroom View Network (CVN), three women claimed they had developed ovarian cancer due to the use of J&J's product. J&J argued the plaintiffs presented flawed science and that its cosmetic talc products undergo extensive safety testing. CVN quoted a J&J spokesperson stating cosmetic talc cases such as these "are being driven by attorneys seeking large verdicts and not the scientific evidence."
This case marked the first trial in St. Louis, Missouri—a central jurisdiction for talc/ovarian cancer cases—since late 2019. The first talc trial against J&J took place there in 2018, when the jury sided with the plaintiffs, ordering J&J to pay nearly $4.7 billion in damages to 22 women and their families.
See related: J&J Could Restructure Talc Business